Research and Development Process, Regulatory Requirements and Clinical Trial of Medical Devices: A Review within the Framework of the Turkish Medicines and Medical Devices Agency (TITCK) and the European Union (Regulation 2017/745)
Oct 2026· Uludağ Üniversitesi Tıp Fakültesi Dergisi· Vol 52· 0 citations· 36 references
TL;DR
This review addresses the medical device lifecycle from a regulatory and scientific perspective, covering device definition and risk-based classification, the design and development process and the supporting quality and risk management standards, preclinical laboratory and biological evaluation, in vivo studies, and clinical evaluation and clinical research requirements.
Abstract
Medical devices encompass a wide range, from simple instruments to complex implants and software, and recent technological advancements have significantly increased both their number and clinical significance. Bringing a medical device from concept to clinical use requires an integrated pathway combining structured research and development, risk management, regulatory compliance, and robust clinical evidence. In the European Union, Regulation 2017/745 (Medical Devices Regulation) superseded previous directives and strengthened the requirements for clinical evaluation, technical certification, post-market surveillance, and traceability. Türkiye has aligned its national framework with this regulation through the Medical Devices Regulation published by the Turkish Medicines and Medical Devices Agency (TITCK). This review addresses the medical device lifecycle from a regulatory and scientific perspective, covering device definition and risk-based classification, the design and development process and the supporting quality and risk management standards, preclinical laboratory and biological evaluation, in vivo studies, and clinical evaluation and clinical research requirements. Particular attention is paid to the alignment between Good Clinical Practices (ISO 14155) and post-market obligations for device research within the Turkish (TITCK) and European (Regulation No. 2017/745) frameworks. Understanding this integrated pathway in the early stages of development is crucial for the efficient, compliant, and patient-centered transfer of medical devices to clinical practice.
The US framework provides more structured and centralised specialised pathways with extensive regulator-developer engagement, whereas the EU system remains decentralised and less harmonised.
A. McDonnell, M. Geraghty, E. Oltmanns et al.· Expert Review of Medical Dev...· 0 citations
OBJECTIVES
Regulatory frameworks for medical devices are continually evolving to keep pace with technological innovation, aiming to ensure safety and efficacy. However, regulatory requirements differ substantially across countries, creating challenges for manufacturers, regulators, and timely patient access to medical...
Bunchai Chongmelaxme, Nargis Saharan, Kok Pim Kua· Value in Health Regional Iss...· 0 citations
A comparative review of orphan drug policies and designation criteria implemented by the US Food and Drug Administration, the European Medicines Agency, and Japan's Pharmaceuticals and Medical Devices Agency is performed, assessing their influence on development, approval, and access.
Robinraja Elango, Russell Martin, S. Mutta· Farmacia Hospitalaria· 0 citations
ABSTRACT Introduction India’s medical device regulatory landscape has undergone fundamental transformation over the past decade, with the Medical Device Rules (MDR) 2017 establishing the country’s first purpose-built, risk-stratified regulatory architecture. This review examines that decade of reform to assess India’s...
N. Kamble, P. Balakshe, A. Velhal et al.· Expert Review of Medical Dev...· 0 citations
The European Union medical device sector is analysed in several largely separate strands of the literature: regulatory studies of the Medical Device Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR), innovation research on individual technology classes, commercial market reporting, and health-policy work o...
B. Azamatov, M. Sadenova, S. Boldyryev· Healthcare· 0 citations
Medical device clinical trials present distinctive regulatory and methodological challenges-including device-specific classification, engineering-based endpoints, operator-dependent performance, device-related safety considerations, and lifecycle evidence obligations-that differ from those of pharmaceutical trials. In...
Wo-Yun Lee, Chien-Chen Lin, Guang-Huar Young et al.· Frontiers in Digital Health· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.